Burns

Genzyme Jumps on Positive Test Results, Takeover Rumors

It's interesting that rumors of Pfizer making moves against both Biogen and Genzyme came out the same day. Which would be a better deal? In my opinion Genzyme is the better fit. It seems to have a higher growth potential and the recent success of its new MS drug is great news to investors. It also doesn't hurt that many of the execs at both Pfizer and Genzyme are on the faculty at Harvard Medical School www.newsvisual.com/new... , making initial negotiations fairly easy. As far as Biogen goes, Pfizer might be interested, but then they would have to go up against Carl Icahn. However it is possible that Icahn could support a takeover of Biogen by Pfizer.